NRXP

NRX Pharmaceuticals, Inc. $2.17 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.8%
Next 1 week
+2.3%
Next 1 month
+5.4%
Seasonality
Mildly positive window
Next 30 days (to Dec 2): +0.6% median, 62% of the last 8 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 4
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.16%/day.
Mean-reversion stats →
1-month breakdown — Market · β 2.29 +5.5% · Seasonal tilt (8y) -0.1%
$4M/day volume 87% volatility -28% 1-year
52-week range · 16% of the way up · -57% from the high
$1.62$5.05

Earnings Full history →

Next report 2026-11-12 (Thursday, after close, in 10 days) · EPS est. -0.15.

1-day std dev
8.5%
Finished up
53%
Biggest pop
+20.3%
Biggest drop
-15.3%

Standard deviation of the close-to-close move over the last 17 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-14 miss -0.13 -0.24 -87.8% -5.2% +4.9% +5.5%
2026-05-15 beat -0.11 -0.04 +59.6% +3.4% -5.0% +31.4%
2026-03-23 beat -0.08 0.18 +329.1% +6.8% +20.3% +20.3%
2025-11-14 miss -0.02 -0.51 -2938.4% -8.0% -15.3% -10.0%
2025-08-18 miss -0.23 -0.98 -326.1% -1.0% -4.5% -6.9%
2025-05-15 miss -0.25 -0.34 -36.0% -2.1% +2.1% +9.2%
2025-03-14 miss -0.37 -0.77 -108.1% +0.0% -12.8% -11.9%
2024-11-14 beat -0.66 -0.15 +77.3% +0.0% +2.6% +8.6%
2024-08-14 miss -0.69 -0.75 -7.9% +3.5% -6.5% +9.7%
2024-05-14 miss -0.55 -0.74 -34.5% +1.6% +1.6% +22.6%
2024-03-29 beat -0.80 -0.50 +37.5% -6.1% -4.8% -1.7%
2023-11-13 beat -1.15 -0.70 +39.1% +4.2% +4.2% -12.5%
2023-08-14 beat -1.40 -1.20 +14.3% -1.5% +2.7% -8.8%
2023-05-15 miss -1.30 -1.60 -23.1% +6.2% -7.3% -4.6%
2023-03-30 miss -1.45 -1.60 -10.3% -0.9% -10.6% -22.7%
2022-11-14 -1.40 -1.40 — +1.1% +3.6% +18.9%
2022-08-15 miss -1.00 -1.10 -10.0% +0.8% +4.5% -5.2%

Not investment advice.